Connecticut awarded $2.3 million in grants for Durata Therapeutics Inc. to establish an office in Branford.
As first reported Sept. 10 by the Fairfield County Business Journal, Durata is leasing nearly 18,000 square feet of space in Branford for research, clinical and regulatory work. Originally located in Morristown, N.J., the company recently established corporate offices in Chicago.
The office of Gov. Dannel P. Malloy stated Durata will invest $13 million in its new facility, creating up to 80 jobs in Branford.
Founded in late 2009 through Pfizer Inc.’s divestment of Vicuron Pharmaceuticals, Durata’s lead drug candidate would treat patients with acute bacterial skin infections. Durata plans to file an application with the Food and Drug Administration in the first half of 2013.
The company raised $74 million in an initial public offering of stock this past July, after reporting an $11.5 million loss in the second quarter and $33.6 million in assets as of June 30.
